Lobectomy versus stereotactic body radiotherapy for stage I non–small cell lung cancer: Post hoc analysis dressed up as level-1 evidence?

Author:

Meyers Bryan F.,Puri Varun,Broderick Stephen R.,Samson Pamela,Keogan Kathleen,Crabtree Traves D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference11 articles.

1. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomized trials;Chang;Lancet Oncol,2015

2. SABR in early operable lung cancer: time for evidence;Treasure;Lancet Oncol,2015

3. American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: A randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer;Fernando;J Thorac Cardiovasc Surg,2012

4. Randomized Study to Compare CyperKnife to Surgical Resection in Stage I Non–Small Cell Lung Cancer (STARS). Available at: https://clinicaltrials.gov/archive/NCT00840749/2009_02_09. Accessed June 2015.

5. Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung Cancer (ROSEL). Available at: https://clinicaltrials.gov/ct2/show/NCT00687986. Accessed June 2015.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3